EUVIMEDEUVIMED entdecken
Fallbericht

Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-β-lactamase–Producing Escherichia coli Causing Fatal Bloodstream Infection

Fiona Senchyna, Kanagavel Murugesan, William Rotunno, Sruti S Nadimpalli, Stan Deresinski, Niaz Banaei iD

Clinical Infectious Diseases · 14.06.2024 · 78 (6) · 1425-1428

DOI: 10.1093/cid/ciad759 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Infectious Diseases, online erschienen am 30.01.2024. Verfasst von Fiona Senchyna und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Azabicyclo Compounds, beta-Lactamases, Aztreonam, Drug Combinations. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Stanford Department of Pathology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a fatal case of New Delhi metallo-β-lactamase (NDM)–producing Escherichia coli in a bacteremic patient with sequential failure of aztreonam plus ceftazidime-avibactam followed by cefiderocol. Acquired resistance was documented phenotypically and mediated through preexisting and acquired mutations. This case highlights the need to rethink optimal treatment for NDM-producing organisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Azabicyclo Compoundsbeta-LactamasesAztreonamDrug CombinationsCeftazidimeAnti-Bacterial AgentsEscherichia coliEscherichia coli InfectionsCefiderocolBacteremiaCephalosporinsTreatment FailureHumansFatal OutcomeMicrobial Sensitivity TestsMaleDrug Resistance, Multiple, Bacterial

Stichwörter der Autor:innen

New Delhi metallo-β-lactamaseavibactamaztreonamcarbapenemasecefiderocol

Substanzen

Azabicyclo Compoundsbeta-LactamasesAztreonamavibactam, ceftazidime drug combinationDrug CombinationsCeftazidimeAnti-Bacterial AgentsCefiderocolCephalosporinsbeta-lactamase NDM-1

Autor:innen und Institutionen

  • Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
  • Clinical Microbiology Laboratory, Stanford University Medical Center,Palo Alto, California, USA.
  • Division of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
  • Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Niaz Banaei

Förderung

  • Stanford Department of Pathology

Zitieren

APA

Senchyna, F., Murugesan, K., Rotunno, W., Nadimpalli, S. S., Deresinski, S., & Banaei, N. (2024). Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-β-lactamase–Producing Escherichia coli Causing Fatal Bloodstream Infection. Clinical Infectious Diseases, 78(6), 1425-1428. https://doi.org/10.1093/cid/ciad759

Vancouver

Senchyna F, Murugesan K, Rotunno W, Nadimpalli SS, Deresinski S, Banaei N. Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-β-lactamase–Producing Escherichia coli Causing Fatal Bloodstream Infection. Clinical Infectious Diseases. 2024;78(6):1425-1428. doi:10.1093/cid/ciad759

BibTeX
@article{Senchyna2024,
  author = {Senchyna, Fiona and Murugesan, Kanagavel and Rotunno, William and Nadimpalli, Sruti S and Deresinski, Stan and Banaei, Niaz},
  title = {Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-β-lactamase–Producing Escherichia coli Causing Fatal Bloodstream Infection},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {78},
  number = {6},
  pages = {1425--1428},
  doi = {10.1093/cid/ciad759}
}
Kostenlos starten →